Your browser doesn't support javascript.
loading
[Research Progress of Fibroblast Growth Factor Receptor Signaling Pathway in Breast Cancer].
Guo, Qiu-Sheng; Cao, Wen-Ming; Wang, Xiao-Jia.
Afiliación
  • Guo QS; Zhejiang Chinese Medical University,Hangzhou 310053,China.
  • Cao WM; Department of Medical Oncology (Breast Cancer),Cancer Hospital of the University of Chinese Academy of Sciences,Hangzhou 310022,China.
  • Wang XJ; Department of Medical Oncology (Breast Cancer),Cancer Hospital of the University of Chinese Academy of Sciences,Hangzhou 310022,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 44(1): 136-141, 2022 Feb.
Article en Zh | MEDLINE | ID: mdl-35300776
ABSTRACT
Breast cancer,one of the common malignant tumors in women,has shown rising incidence in recent years,posing a serious threat to women's health.The advancement of molecular biology facilitates the revealing of the relationships between signaling pathways and breast cancer.Fibroblast growth factor receptor (FGFR) signaling pathway plays an important role in the proliferation,survival,differentiation,migration,and apoptosis of breast cancer cells.Strategies targeting the FGFR signaling pathway thus exhibit a promising prospect in breast cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Factores de Crecimiento de Fibroblastos Límite: Female / Humans Idioma: Zh Revista: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Factores de Crecimiento de Fibroblastos Límite: Female / Humans Idioma: Zh Revista: Zhongguo Yi Xue Ke Xue Yuan Xue Bao Año: 2022 Tipo del documento: Article País de afiliación: China